In silico receptorome screening of antipsychotic drugs

Molecular Informatics

Volumn 29, Issue 6-7, 2010, Pages 543-551

  Vidal, David ^a   Mestres, Jordi ^b  

^a Chemotargets S L   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Chemical biology; Chemogenomics; Drug repurposing; High throughput screening; Polypharmacology

Indexed keywords

BIOCHEMISTRY;

ANTIPSYCHOTIC DRUG; CHEMICAL BIOLOGY; CHEMOGENOMICS; DRUG REPURPOSING; HIGH THROUGHPUT SCREENING; IN-SILICO; INTERACTION MATRICES; POLYPHARMACOLOGY; PROTEIN TARGETS; REPURPOSING;

COST EFFECTIVENESS;

ADRENERGIC RECEPTOR; ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE RECEPTOR; FLUPHENAZINE; HALOPERIDOL; HISTAMINE RECEPTOR; LOXAPINE; MUSCARINIC RECEPTOR; NEUROLEPTIC AGENT; NEUROTRANSMITTER TRANSPORTER; OLANZAPINE; QUETIAPINE; RECEPTOR; RECEPTOROME; RISPERIDONE; SEROTONIN RECEPTOR; THIORIDAZINE; TIOTIXENE; UNCLASSIFIED DRUG; ZIPRASIDONE; ZOTEPINE;

ACCURACY; ARTICLE; COMPUTER MODEL; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; DATA BASE; DRUG RECEPTOR BINDING; DRUG SCREENING; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN TARGETING; RECEPTOR AFFINITY; VALIDATION STUDY;

EID: 77956837481     PISSN: 18681743     EISSN: 18681751     Source Type: Journal    
DOI: 10.1002/minf.201000055     Document Type: Article

References (41)

1. J. van Os, S. Kapur, Lancet 2009, 374, 635-645.
2. J. Ventimiglia, A. H. Kalali, R. A. McIntyre, Psychiatry (Edgmont) 2009, 6, 12-14.
3. W. Kawohl, F. Schneider, I. Vernaleken, I. Neuner, World J. Biol. Psychiatry 2009, 10, 827-831.
4. S. Kasper, J. Zohar, World J. Biol. Psychiatry 2003, 4, 144-145
5. L. F. Jarskog, S. Miyamoto, J. A. Lieberman, Annu. Rev. Med. 2007, 58, 49-61.
6. a) J. M. Kane, Eur. Neuropsychopharmacol. 2001, 11 (Suppl 4), 397-403;
7. b) T. Kendrik, Br. J. Gen. Pract. 1999, 49, 745-749.
8. A. Farah, Prim. Care Companion J. Clin. Psychiatry 2005, 7, 268-274.
9. a) S. Kapur, G. Remington, R. B. Zipursky, A. A. Wilson, S. Houle, Life Sci. 1995, 57, 103-107;
10. b) S. Kapur, R. B. Zipursky, G. Remington, C. Jones, J. DaSilva, A. A. Wilson, S. Houle, Am. J. Psychiatry 1998, 155, 921-928.
11. a) D. B. Allison, J. L. Mentore, M. Heo, L. P. Chandler, J. C. Cap-pellieri, M. C. Infante, P. J. Weiden, Am. J. Psichiatry 1999, 156, 1686-1696;
12. b) J. W. Newcomer, CNS Drugs 2005, 19 (Suppl 1), 1-93.
13. S. Miyamoto, G. E. Duncan, C. E. Marx, J. A. Lieberman, Mol. Psychiatry 2005, 10, 79-104.
14. R. T. Strachan, G. Ferrara, B. L. Roth, Drug Discov. Today 2006, 11, 708-716.
15. I. Vogt, J. Mestres, Mol. Inf. 2010, 29, 10-14.
16. a) S. Ekins, J. Mestres, B. Testa, Br. J. Pharmacol. 2007, 152, 9-20;
17. b) J. Bajorath, Curr. Opin. Chem. Biol. 2008, 12, 352-358;
18. c) D. Rognan, Mol. Inf. 2010, 29, 176-187.
19. M.J. Keiser, B. L. Roth, B.N. Armbruster, P. Ernsberger, J.J. Irwin, B. K. Shoichet, Nat. Biotechnol. 2007, 25, 197-206.
20. E. Gregori-Puigjane, J. Mestres, Comb. Chem. High Throughput Screen. 2008, 11, 669-676.
21. P. Prathipati, N. L Ma, U. H. Manjunatha, A. Bender, J. Prot. Res. 2009, 8, 2788-2798.
22. M.J. Keiser, V. Setola, J.J. Irwin, C. Laggner, A.I. Abbas, S.J. Hufeisen, N. H. Jensen, M. B. Kuijer, R. C. Matos, T. B. Tran, R. Whaley, R. A. Glennon, J. Hert, K. L. H. Thomas, D. D. Edwards, B. K. Shoichet, B. L. Roth, Nature 2009, 462, 175-182
23. P. Muller, G. Lena, E. Boilard, S. Bezzine, G. Lambeau, G. Gui-chard, D. Rognan, J. Med. Chem. 2006, 49, 6768-6778
24. J. M. Rollinger, D. Schuster, B. Danzl, S. Schwaiger, P. Markt, M. Schmidtke, J. Gertsch, S. Raduner, G. Wolber, T Langer, H. Stuppner, Planta Med. 2009, 75, 195-204
25. F. M. Areias, J. M. Brea, E. Gregori-Puigjane, M. E. A. Zaki, A. Carvalho, E. Dominguez, H. Gutierrez-de-Teran, F. M. ProenÅa, M. I. Loza, J. Mestres, Bioorg. Med. Chem. 2010, 18, 3043-3052.
26. B. L Roth, D.J. Sheffler, W. K. Kroeze, Nat. Rev. Drug Discov. 2004, 3, 353-359
27. ChEMBL database (http://www.ebi.ac.uk/chembldb).
28. Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program, Contract # HHSN-271-2008-00025-C (NIMH PDSP). The NIMH PDSP is Directed by Bryan L. Roth MD, PhD at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscol at NIMH, Bethesda MD, USA. (http://pdsp. med.unc.edu/).
29. T Liu, Y. Lin, X. Wen, R. N. Jorrisen, M. K. Gilson, Nucleic Acids Res. 2007, 35, D198-D201.
30. A. J. Harmar, R. A. Hills, E. M. Rosser, M. Jones, O. P. Buneman, D. R. Dunbar, S. D. Greenhill, V. A. Hale, J. L. Sharman, T I. Bonner, W. A. Catterall, A. P. Davenport, P. Delagrange, C. T Dollery, S. M. Foord, G. A. Gutman, V. Laudet, R. R. Neubig, E.H. Ohlstein, R. W. Olsen, J. Peters, J. P. Pin, R. R. Ruffolo, D. B. Searls, M. W. Wright, M. Spedding, Nucleic Acids Res. 2009, 37, D680-D685.
31. D. Vidal, R. Garcia-Serna, J. Mestres, Meth. Mol. Biol. 2011, 672, in press.
32. a) E. Gregori-Puigjane, J. Mestres, J. Chem. Inf. Model. 2006, 46, 1615-1622;
33. b) J. Mestres, L. Martin-Couce, E. Gregori-Puigjane, M. Cases, S. Boyer, J. Chem. Inf. Model. 2006, 46, 2725-2736
34. D. Horvath, C. Jeandenans, J. Chem. Inf. Comput. Sci. 2003, 43, 680-690
35. a) G. Schneider, W. Neidhart, T Giller, G. Schmid, Angew. Chem. Int. Ed. 1999, 38, 2894-2896;
36. b) T Noeske, B.C. Sasse, H. Stark, C. G. Parsons, T Weil, G. Schneider, ChemMedChem 2006, 1, 1066-1068.
37. C. E. Shannon, W. Weaver, in The Mathematical Theory of Communication, University of Illinois, Urbana, IL 1949.
38. J. Bajorath, L. Peltason, M. Wawer, R. Guha, M. S. Lajiness, J. H. van Drie, Drug Discov. Today 2009, 14, 698-705.
39. D. Shepard, Proc. 1968 ACM Nat. Conf. 1968, 517-524.
40. M. Hassan, R. D. Brown, S. Varma-O'Brien, D. Rogers, Mol. Divers. 2006, 10, 283-299.
41. M. Olah, M. Mracec, L. Ostopovici, R. Rad, A. Bora, N. Hadaru-ga, I. Olah, M. Banda, Z. Simon, T I. Oprea, in Chemoinformatics in Drug Discovery (Ed: T I. Oprea), Wiley-VCH, New York, 2004, pp. 223-239.